In 2024, the global market size of Flu Vaccine was estimated to be worth US$ 8955 million and is forecast to reach approximately US$ 12990 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.

Flu Vaccine Market

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.

Global key players of Vaccine for Influenza include Sanofi, CSL and GSK, etc. The top five players hold a share about 75%. North America is the largest market, has a share about 50%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Flu Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Flu Vaccine.

The Flu Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Flu Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Flu Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Flu Vaccine Market Report

Report Metric	Details
Report Name	Flu Vaccine Market
Forecasted market size in 2031	approximately US$ 12990 million
CAGR	5.5%
Forecasted years	2025 - 2031
Segment by Type	Trivalent Influenza Vaccine Quadrivalent Influenza Vaccine
Segment by Application	6 Months to 3 Years > 3 Years
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac, BCHT, Jiangsu GDK, KM Biologics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Flu Vaccine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Flu Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Flu Vaccine sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the Flu Vaccine Market size in 2031?

Ans: The Flu Vaccine Market size in 2031 will be approximately US$ 12990 million.

What is the market share of major companies in Flu Vaccine Market?

Ans: The top five players hold a share about 75%.

What is the Flu Vaccine Market share by region?

Ans: North America is the largest market, has a share about 50%.

Who are the main players in the Flu Vaccine Market report?

Ans: The main players in the Flu Vaccine Market are Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac, BCHT, Jiangsu GDK, KM Biologics

What are the Application segmentation covered in the Flu Vaccine Market report?

Ans: The Applications covered in the Flu Vaccine Market report are 6 Months to 3 Years, > 3 Years

What are the Type segmentation covered in the Flu Vaccine Market report?

Ans: The Types covered in the Flu Vaccine Market report are Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine

1 Study Coverage

1.1 Flu Vaccine Product Introduction

1.2 Market by Type

1.2.1 Global Flu Vaccine Market Size Growth Rate by Type (2020 VS 2024 VS 2031)

1.2.2 Trivalent Influenza Vaccine

1.2.3 Quadrivalent Influenza Vaccine

1.3 Market by Application

1.3.1 Global Flu Vaccine Market Size Growth Rate by Application (2020 VS 2024 VS 2031)

1.3.2 6 Months to 3 Years

1.3.3 > 3 Years

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Flu Vaccine Market Size Estimates and Forecasts

2.1.1 Global Flu Vaccine Revenue 2020-2031

2.1.2 Global Flu Vaccine Sales 2020-2031

2.2 Flu Vaccine Market Size by Region: 2024 Versus 2031

2.3 Flu Vaccine Sales by Region (2020-2031)

2.3.1 Global Flu Vaccine Sales by Region: 2020-2025

2.3.2 Global Flu Vaccine Sales Forecast by Region (2026-2031)

2.3.3 Global Flu Vaccine Sales Market Share by Region (2020-2031)

2.4 Flu Vaccine Market Estimates and Projections by Region (2026-2031)

2.4.1 Global Flu Vaccine Revenue by Region: 2020-2025

2.4.2 Global Flu Vaccine Revenue Forecast by Region (2026-2031)

2.4.3 Global Flu Vaccine Revenue Market Share by Region (2020-2031)

3 Market Segments

3.1 Breakdown Data by Type

3.1.1 Global Flu Vaccine Sales by Type (2020-2031)

3.1.1.1 Global Flu Vaccine Sales Volume by Type (2020-2031)

3.1.1.2 Global Flu Vaccine Sales Market Share by Type (2020-2031)

3.1.2 Global Flu Vaccine Revenue by Type (2020-2031)

3.1.2.1 Global Flu Vaccine Revenue by Type (2020-2031)

3.1.2.2 Global Flu Vaccine Revenue Market Share by Type (2020-2031)

3.1.3 Flu Vaccine Average Selling Price (ASP) by Type (2020-2031)

3.2 Breakdown Data by Application

3.2.1 Global Flu Vaccine Sales by Application (2020-2031)

3.2.1.1 Global Flu Vaccine Sales Volume by Application (2020-2031)

3.2.1.2 Global Flu Vaccine Sales Market Share by Application (2020-2031)

3.2.2 Global Flu Vaccine Revenue by Application (2020-2031)

3.2.2.1 Global Flu Vaccine Revenue by Application (2020-2031)

3.2.2.2 Global Flu Vaccine Revenue Market Share by Application (2020-2031)

3.2.3 Flu Vaccine Average Selling Price (ASP) by Application (2020-2031)

3.3 by Type and by Application Crossing Analysis

3.3.1 Trivalent Influenza Vaccine of Flu Vaccine Revenue Market Share by Application

3.3.2 Quadrivalent Influenza Vaccine of Flu Vaccine Revenue Market Share by Application

4 Global Flu Vaccine by Manufacturers

4.1 Global Top Flu Vaccine Manufacturers by Sales (2020-2025)

4.1.1 Global Flu Vaccine Sales by Manufacturer (2020-2025)

4.1.2 Global Flu Vaccine Sales Market Share by Manufacturer (2020-2025)

4.2 Global Top Flu Vaccine Manufacturers by Revenue (2020-2025)

4.2.1 Global Flu Vaccine Revenue by Manufacturer (2020-2025)

4.2.2 Global Flu Vaccine Revenue Share by Manufacturer (2020-2025)

4.3 Global Flu Vaccine Price by Manufacturer (2020-2025)

4.4 Competitive Landscape

4.4.1 Key Flu Vaccine Manufacturers Covered: Ranking by Revenue

4.4.2 Global Flu Vaccine Market Concentration Ratio (CR5 and HHI) & (2020-2025)

4.4.3 Global Flu Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.5 Global Flu Vaccine Manufacturing Base Distribution, Product Type

4.5.1 Flu Vaccine Manufacturers Manufacturing Base Distribution, Headquarters

4.5.2 Date of International Manufacturers Enter into Flu Vaccine Market

4.5.3 Manufacturers Flu Vaccine Product Type and Application

4.5.4 Trivalent Influenza Vaccine Market Sales of Flu Vaccine by Manufacturer

4.5.5 Quadrivalent Influenza Vaccine Market Sales of Flu Vaccine by Manufacturer

4.6 Manufacturers Mergers & Acquisitions, Expansion Plans

5 Company Profiles

5.1 Sanofi

5.1.1 Sanofi Company Information

5.1.2 Sanofi Description, Business Overview

5.1.3 Sanofi Flu Vaccine Products Offered

5.1.4 Sanofi Flu Vaccine Sales, Revenue and Gross Margin (2020-2025)

5.1.5 Sanofi Flu Vaccine Sales by Product in 2024

5.1.6 Sanofi Flu Vaccine Sales by Application in 2024

5.1.7 Sanofi Flu Vaccine Sales by Geographic Area in 2024

5.1.8 Sanofi Recent Developments

5.2 CSL

5.2.1 CSL Company Information

5.2.2 CSL Description, Business Overview

5.2.3 CSL Flu Vaccine Products Offered

5.2.4 CSL Flu Vaccine Sales, Revenue and Gross Margin (2020-2025)

5.2.5 CSL Flu Vaccine Sales by Product in 2024

5.2.6 CSL Flu Vaccine Sales by Application in 2024

5.2.7 CSL Flu Vaccine Sales by Geographic Area in 2024

5.2.8 CSL Recent Developments

5.3 GSK

5.3.1 GSK Company Information

5.3.2 GSK Description, Business Overview

5.3.3 GSK Flu Vaccine Products Offered

5.3.4 GSK Flu Vaccine Sales, Revenue and Gross Margin (2020-2025)

5.3.5 GSK Flu Vaccine Sales by Product in 2024

5.3.6 GSK Flu Vaccine Sales by Application in 2024

5.3.7 GSK Flu Vaccine Sales by Geographic Area in 2024

5.3.8 GSK Recent Developments

5.4 Viatris

5.4.1 Viatris Company Information

5.4.2 Viatris Description, Business Overview

5.4.3 Viatris Flu Vaccine Products Offered

5.4.4 Viatris Flu Vaccine Sales, Revenue and Gross Margin (2020-2025)

5.4.5 Viatris Flu Vaccine Sales by Product in 2024

5.4.6 Viatris Flu Vaccine Sales by Application in 2024

5.4.7 Viatris Flu Vaccine Sales by Geographic Area in 2024

5.4.8 Viatris Recent Developments

5.5 AstraZeneca

5.5.1 AstraZeneca Company Information

5.5.2 AstraZeneca Description, Business Overview

5.5.3 AstraZeneca Flu Vaccine Products Offered

5.5.4 AstraZeneca Flu Vaccine Sales, Revenue and Gross Margin (2020-2025)

5.5.5 AstraZeneca Flu Vaccine Sales by Product in 2024

5.5.6 AstraZeneca Flu Vaccine Sales by Application in 2024

5.5.7 AstraZeneca Flu Vaccine Sales by Geographic Area in 2024

5.5.8 AstraZeneca Recent Developments

5.6 Hualan Bio

5.6.1 Hualan Bio Company Information

5.6.2 Hualan Bio Description, Business Overview

5.6.3 Hualan Bio Flu Vaccine Products Offered

5.6.4 Hualan Bio Flu Vaccine Sales, Revenue and Gross Margin (2020-2025)

5.6.5 Hualan Bio Flu Vaccine Sales by Product in 2024

5.6.6 Hualan Bio Flu Vaccine Sales by Application in 2024

5.6.7 Hualan Bio Flu Vaccine Sales by Geographic Area in 2024

5.6.8 Hualan Bio Recent Developments

5.7 Changchun Institute of Biological

5.7.1 Changchun Institute of Biological Company Information

5.7.2 Changchun Institute of Biological Description, Business Overview

5.7.3 Changchun Institute of Biological Flu Vaccine Products Offered

5.7.4 Changchun Institute of Biological Flu Vaccine Sales, Revenue and Gross Margin (2020-2025)

5.7.5 Changchun Institute of Biological Flu Vaccine Sales by Product in 2024

5.7.6 Changchun Institute of Biological Flu Vaccine Sales by Application in 2024

5.7.7 Changchun Institute of Biological Flu Vaccine Sales by Geographic Area in 2024

5.7.8 Changchun Institute of Biological Recent Developments

5.8 Sinovac

5.8.1 Sinovac Company Information

5.8.2 Sinovac Description, Business Overview

5.8.3 Sinovac Flu Vaccine Products Offered

5.8.4 Sinovac Flu Vaccine Sales, Revenue and Gross Margin (2020-2025)

5.8.5 Sinovac Flu Vaccine Sales by Product in 2024

5.8.6 Sinovac Flu Vaccine Sales by Application in 2024

5.8.7 Sinovac Flu Vaccine Sales by Geographic Area in 2024

5.8.8 Sinovac Recent Developments

5.9 BCHT

5.9.1 BCHT Company Information

5.9.2 BCHT Description, Business Overview

5.9.3 BCHT Flu Vaccine Products Offered

5.9.4 BCHT Flu Vaccine Sales, Revenue and Gross Margin (2020-2025)

5.9.5 BCHT Flu Vaccine Sales by Product in 2024

5.9.6 BCHT Flu Vaccine Sales by Application in 2024

5.9.7 BCHT Flu Vaccine Sales by Geographic Area in 2024

5.9.8 BCHT Recent Developments

5.10 Jiangsu GDK

5.10.1 Jiangsu GDK Company Information

5.10.2 Jiangsu GDK Description, Business Overview

5.10.3 Jiangsu GDK Flu Vaccine Products Offered

5.10.4 Jiangsu GDK Flu Vaccine Sales, Revenue and Gross Margin (2020-2025)

5.10.5 Jiangsu GDK Flu Vaccine Sales by Product in 2024

5.10.6 Jiangsu GDK Flu Vaccine Sales by Application in 2024

5.10.7 Jiangsu GDK Flu Vaccine Sales by Geographic Area in 2024

5.10.8 Jiangsu GDK Recent Developments

5.11 KM Biologics

5.11.1 KM Biologics Company Information

5.11.2 KM Biologics Description, Business Overview

5.11.3 KM Biologics Flu Vaccine Products Offered

5.11.4 KM Biologics Flu Vaccine Sales, Revenue and Gross Margin (2020-2025)

5.11.5 KM Biologics Flu Vaccine Sales by Product in 2024

5.11.6 KM Biologics Flu Vaccine Sales by Application in 2024

5.11.7 KM Biologics Flu Vaccine Sales by Geographic Area in 2024

5.11.8 KM Biologics Recent Developments

6 North America

6.1 North America Flu Vaccine Market Size YoY Growth 2020-2031

6.2 North America Flu Vaccine Market Facts & Figures by Country

6.2.1 North America Flu Vaccine Sales by Country (2020-2031)

6.2.2 North America Flu Vaccine Revenue by Country (2020-2031)

6.3 North America Flu Vaccine Sales by Type (2020-2025)

6.4 North America Flu Vaccine Sales by Application (2020-2025)

7 Asia-Pacific

7.1 Asia-Pacific Flu Vaccine Market Size YoY Growth 2020-2031

7.2 Asia-Pacific Flu Vaccine Market Facts & Figures by Region

7.2.1 Asia-Pacific Flu Vaccine Sales by Region (2020-2031)

7.2.2 Asia-Pacific Flu Vaccine Revenue by Region (2020-2031)

7.3 Asia-Pacific Flu Vaccine Sales by Type (2020-2025)

7.4 Asia-Pacific Flu Vaccine Sales by Application (2020-2025)

8 Europe

8.1 Europe Flu Vaccine Market Size YoY Growth 2020-2031

8.2 Europe Flu Vaccine Market Facts & Figures by Country

8.2.1 Europe Flu Vaccine Sales by Country (2020-2031)

8.2.2 Europe Flu Vaccine Revenue by Country (2020-2031)

8.3 Europe Flu Vaccine Sales by Type (2020-2025)

8.4 Europe Flu Vaccine Sales by Application (2020-2025)

9 Latin America

9.1 Latin America Flu Vaccine Market Size YoY Growth 2020-2031

9.2 Latin America Flu Vaccine Market Facts & Figures by Country

9.2.1 Latin America Flu Vaccine Sales by Country (2020-2031)

9.2.2 Latin America Flu Vaccine Revenue by Country (2020-2031)

9.3 Latin America Flu Vaccine Sales by Type (2020-2025)

9.4 Latin America Flu Vaccine Sales by Application (2020-2025)

10 Middle East and Africa

10.1 Latin America Flu Vaccine Market Size YoY Growth 2020-2031

10.2 Middle East and Africa Flu Vaccine Market Facts & Figures by Country

10.2.1 Middle East and Africa Flu Vaccine Sales by Country (2020-2031)

10.2.2 Middle East and Africa Flu Vaccine Revenue by Country (2020-2031)

10.3 Middle East and Africa Flu Vaccine Sales by Type (2020-2025)

10.4 Middle East and Africa Flu Vaccine Sales by Application (2020-2025)

11 Supply Chain and Sales Channel analysis

11.1 Flu Vaccine Supply Chain Analysis

11.2 Flu Vaccine Key Raw Materials and Upstream Suppliers

11.3 Flu Vaccine Clients Analysis

11.4 Flu Vaccine Sales Channel and Sales Model Analysis

11.4.1 Flu Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales

11.4.2 Flu Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales

11.4.3 Flu Vaccine Distributors

12 Flu Vaccine Market Dynamics

12.1 Flu Vaccine Industry Trends

12.2 Flu Vaccine Market Drivers

12.3 Flu Vaccine Market Challenges

12.4 Flu Vaccine Market Restraints

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.1.1 Research Programs/Design

14.1.1.2 Market Size Estimation

14.1.1.3 Market Breakdown and Data Triangulation

14.1.2 Data Source

14.1.2.1 Secondary Sources

14.1.2.2 Primary Sources

14.2 Author Details

14.3 Disclaimer

FEATURED COMPANIES

Viatris

Astrazeneca plc

Hualan Bio

Changchun Institute of Biological

List of Tables

Table 1. Global Flu Vaccine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Flu Vaccine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Flu Vaccine Market Size by Region (US$ Million): 2024 VS 2031

Table 4. Global Flu Vaccine Sales by Region (2020-2025) & (M Doses)

Table 5. Global Flu Vaccine Sales Forecast by Region (2026-2031) & (M Doses)

Table 6. Global Flu Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 7. Global Flu Vaccine Revenue Forecast by Region (2026-2031) & (US$ Million)

Table 8. Global Flu Vaccine Sales Volume by Type (2020-2025) & (M Doses)

Table 9. Global Flu Vaccine Sales Volume by Type (2026-2031) & (M Doses)

Table 10. Global Flu Vaccine Revenue by Type (2020-2025) & (US$ Million)

Table 11. Global Flu Vaccine Revenue Forecast by Type (2026-2031) & (US$ Million)

Table 12. Global Flu Vaccine Sales Volume by Application (2020-2025) & (M Doses)

Table 13. Global Flu Vaccine Sales Volume by Application (2026-2031) & (M Doses)

Table 14. Global Flu Vaccine Revenue by Application (2020-2025) & (US$ Million)

Table 15. Global Flu Vaccine Revenue by Application (2026-2031) & (US$ Million)

Table 16. Global Flu Vaccine Sales by Manufacturer (2020-2025) & (M Doses)

Table 17. Global Flu Vaccine Sales Share by Manufacturer (2020-2025)

Table 18. Flu Vaccine Revenue by Manufacturer (2020-2025) & (US$ Million)

Table 19. Flu Vaccine Revenue Share by Manufacturer (2020-2025)

Table 20. Key Manufacturers Flu Vaccine Price (2020-2025) & (USD/Doses)

Table 21. Ranking of Global Top Flu Vaccine Manufacturers by Revenue (US$ Million) in 2024

Table 22. Global Flu Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)

Table 23. Global Flu Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Flu Vaccine as of 2024)

Table 24. Flu Vaccine Manufacturers Manufacturing Base Distribution and Headquarters

Table 25. Date of International Manufacturers Enter into Flu Vaccine Market

Table 26. Manufacturers Flu Vaccine Product Type and Application

Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 28. Sanofi Company Information

Table 29. Sanofi Description and Business Overview

Table 30. Sanofi Flu Vaccine Product

Table 31. Sanofi Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)

Table 32. Sanofi Sales Proportion of Flu Vaccine by Product in 2024

Table 33. Sanofi Sales Proportion of Flu Vaccine by Application in 2024

Table 34. Sanofi Sales Proportion of Flu Vaccine by Geographic Area in 2024

Table 35. Sanofi Recent Developments

Table 36. CSL Company Information

Table 37. CSL Description and Business Overview

Table 38. CSL Flu Vaccine Product

Table 39. CSL Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)

Table 40. CSL Sales Proportion of Flu Vaccine by Product in 2024

Table 41. CSL Sales Proportion of Flu Vaccine by Application in 2024

Table 42. CSL Sales Proportion of Flu Vaccine by Geographic Area in 2024

Table 43. CSL Recent Developments

Table 44. GSK Company Information

Table 45. GSK Description and Business Overview

Table 46. GSK Flu Vaccine Product

Table 47. GSK Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)

Table 48. GSK Sales Proportion of Flu Vaccine by Product in 2024

Table 49. GSK Sales Proportion of Flu Vaccine by Application in 2024

Table 50. GSK Sales Proportion of Flu Vaccine by Geographic Area in 2024

Table 51. GSK Recent Developments

Table 52. Viatris Company Information

Table 53. Viatris Description and Business Overview

Table 54. Viatris Flu Vaccine Product

Table 55. Viatris Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)

Table 56. Viatris Sales Proportion of Flu Vaccine by Product in 2024

Table 57. Viatris Sales Proportion of Flu Vaccine by Application in 2024

Table 58. Viatris Sales Proportion of Flu Vaccine by Geographic Area in 2024

Table 59. Viatris Recent Developments

Table 60. AstraZeneca Company Information

Table 61. AstraZeneca Description and Business Overview

Table 62. AstraZeneca Flu Vaccine Product

Table 63. AstraZeneca Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)

Table 64. AstraZeneca Sales Proportion of Flu Vaccine by Product in 2024

Table 65. AstraZeneca Sales Proportion of Flu Vaccine by Application in 2024

Table 66. AstraZeneca Sales Proportion of Flu Vaccine by Geographic Area in 2024

Table 67. AstraZeneca Recent Developments

Table 68. Hualan Bio Company Information

Table 69. Hualan Bio Description and Business Overview

Table 70. Hualan Bio Flu Vaccine Product

Table 71. Hualan Bio Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)

Table 72. Hualan Bio Sales Proportion of Flu Vaccine by Product in 2024

Table 73. Hualan Bio Sales Proportion of Flu Vaccine by Application in 2024

Table 74. Hualan Bio Sales Proportion of Flu Vaccine by Geographic Area in 2024

Table 75. Hualan Bio Recent Developments

Table 76. Changchun Institute of Biological Company Information

Table 77. Changchun Institute of Biological Description and Business Overview

Table 78. Changchun Institute of Biological Flu Vaccine Product

Table 79. Changchun Institute of Biological Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)

Table 80. Changchun Institute of Biological Sales Proportion of Flu Vaccine by Product in 2024

Table 81. Changchun Institute of Biological Sales Proportion of Flu Vaccine by Application in 2024

Table 82. Changchun Institute of Biological Sales Proportion of Flu Vaccine by Geographic Area in 2024

Table 83. Changchun Institute of Biological Recent Developments

Table 84. Sinovac Company Information

Table 85. Sinovac Description and Business Overview

Table 86. Sinovac Flu Vaccine Product

Table 87. Sinovac Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)

Table 88. Sinovac Sales Proportion of Flu Vaccine by Product in 2024

Table 89. Sinovac Sales Proportion of Flu Vaccine by Application in 2024

Table 90. Sinovac Sales Proportion of Flu Vaccine by Geographic Area in 2024

Table 91. Sinovac Recent Developments

Table 92. BCHT Company Information

Table 93. BCHT Description and Business Overview

Table 94. BCHT Flu Vaccine Product

Table 95. BCHT Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)

Table 96. BCHT Sales Proportion of Flu Vaccine by Product in 2024

Table 97. BCHT Sales Proportion of Flu Vaccine by Application in 2024

Table 98. BCHT Sales Proportion of Flu Vaccine by Geographic Area in 2024

Table 99. BCHT Recent Developments

Table 100. Jiangsu GDK Company Information

Table 101. Jiangsu GDK Description and Business Overview

Table 102. Jiangsu GDK Flu Vaccine Product

Table 103. Jiangsu GDK Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)

Table 104. Jiangsu GDK Sales Proportion of Flu Vaccine by Product in 2024

Table 105. Jiangsu GDK Sales Proportion of Flu Vaccine by Application in 2024

Table 106. Jiangsu GDK Sales Proportion of Flu Vaccine by Geographic Area in 2024

Table 107. Jiangsu GDK Recent Developments

Table 108. KM Biologics Company Information

Table 109. KM Biologics Description and Business Overview

Table 110. KM Biologics Flu Vaccine Product

Table 111. KM Biologics Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)

Table 112. KM Biologics Sales Proportion of Flu Vaccine by Product in 2024

Table 113. KM Biologics Sales Proportion of Flu Vaccine by Application in 2024

Table 114. KM Biologics Sales Proportion of Flu Vaccine by Geographic Area in 2024

Table 115. KM Biologics Recent Developments

Table 116. North America Flu Vaccine Sales by Country (2020-2025) & (M Doses)

Table 117. North America Flu Vaccine Sales by Country (2026-2031) & (M Doses)

Table 118. North America Flu Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 119. North America Flu Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 120. North America Flu Vaccine Sales by Type (2020-2025) & (M Doses)

Table 121. North America Flu Vaccine Sales by Application (2020-2025) & (M Doses)

Table 122. Asia-Pacific Flu Vaccine Sales by Region (2020-2025) & (M Doses)

Table 123. Asia-Pacific Flu Vaccine Sales by Region (2026-2031) & (M Doses)

Table 124. Asia-Pacific Flu Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 125. Asia-Pacific Flu Vaccine Revenue by Region (2026-2031) & (US$ Million)

Table 126. Asia-Pacific Flu Vaccine Sales by Type (2020-2025) & (M Doses)

Table 127. Asia-Pacific Flu Vaccine Sales by Application (2020-2025) & (M Doses)

Table 128. Europe Flu Vaccine Sales by Country (2020-2025) & (M Doses)

Table 129. Europe Flu Vaccine Sales by Country (2026-2031) & (M Doses)

Table 130. Europe Flu Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 131. Europe Flu Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 132. Europe Flu Vaccine Sales by Type (2020-2025) & (M Doses)

Table 133. Europe Flu Vaccine Sales by Application (2020-2025) & (M Doses)

Table 134. Latin America Flu Vaccine Sales by Country (2020-2025) & (M Doses)

Table 135. Latin America Flu Vaccine Sales by Country (2026-2031) & (M Doses)

Table 136. Latin America Flu Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 137. Latin America Flu Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 138. Latin America Flu Vaccine Sales by Type (2020-2025) & (M Doses)

Table 139. Latin America Flu Vaccine Sales by Application (2020-2025) & (M Doses)

Table 140. Middle East and Africa Flu Vaccine Sales by Country (2020-2025) & (M Doses)

Table 141. Middle East and Africa Flu Vaccine Sales by Country (2026-2031) & (M Doses)

Table 142. Middle East and Africa Flu Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 143. Middle East and Africa Flu Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 144. Middle East and Africa Flu Vaccine Sales by Type (2020-2025) & (M Doses)

Table 145. Middle East and Africa Flu Vaccine Sales by Application (2020-2025) & (M Doses)

Table 146. Flu Vaccine Key Raw Materials, Industry Status and Trend

Table 147. Flu Vaccine Key Raw Materials and Upstream Suppliers

Table 148. Flu Vaccine Clients Status and Trend

Table 149. Flu Vaccine Typical Clients

Table 150. Flu Vaccine Distributors

Table 151. Flu Vaccine Market Trends

Table 152. Flu Vaccine Market Drivers

Table 153. Flu Vaccine Market Challenges

Table 154. Flu Vaccine Market Restraints

Table 155. Research Programs/Design for This Report

Table 156. Key Data Information from Secondary Sources

Table 157. Key Data Information from Primary Sources

Table 158. QYR Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Flu Vaccine Product Picture

Figure 2. Global Flu Vaccine Market Size by Type (US$ Million): 2020 VS 2024 VS 2031

Figure 3. Global Flu Vaccine Sales Market Share by Type in 2024 & 2031

Figure 4. Trivalent Influenza Vaccine Product Picture

Figure 5. Quadrivalent Influenza Vaccine Product Picture

Figure 6. Global Flu Vaccine Market Size by Application (US$ Million): 2020 VS 2024 VS 2031

Figure 7. Global Flu Vaccine Sales Market Share by Application in 2024 & 2031

Figure 8. 6 Months to 3 Years

Figure 9. > 3 Years

Figure 10. Flu Vaccine Report Years Considered

Figure 11. Global Flu Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Flu Vaccine Market Size 2020-2031 (US$ Million)

Figure 13. Global Flu Vaccine Sales 2020-2031 (M Doses)

Figure 14. Global Flu Vaccine Sales Market Share Forecast by Region (2020-2031)

Figure 15. Global Flu Vaccine Revenue Market Share by Region (2020-2031)

Figure 16. Global Flu Vaccine Sales Market Share Forecast by Type (2020-2031)

Figure 17. Global Flu Vaccine Revenue Market Share Forecast by Type (2020-2031)

Figure 18. Flu Vaccine Average Selling Price (ASP) by Type (2020-2025) & (USD/Doses)

Figure 19. Global Flu Vaccine Sales Market Share Forecast by Application (2020-2031)

Figure 20. Global Flu Vaccine Revenue Market Share Forecast by Application (2020-2031)

Figure 21. Flu Vaccine Average Selling Price (ASP) by Application (2020-2025) & (USD/Doses)

Figure 22. Trivalent Influenza Vaccine of Flu Vaccine Revenue Market Share by Application, 2024 VS 2031

Figure 23. Quadrivalent Influenza Vaccine of Flu Vaccine Revenue Market Share by Application, 2024 VS 2031

Figure 24. Global Flu Vaccine Sales Share by Manufacturer in 2024

Figure 25. Flu Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 26. Trivalent Influenza Vaccine Market Sales Proportion by Manufacturer in 2024

Figure 27. Quadrivalent Influenza Vaccine Market Sales Proportion by Manufacturer in 2024

Figure 28. North America Flu Vaccine Revenue 2020-2031 (US$ Million)

Figure 29. North America Flu Vaccine Sales Market Share by Type (2020-2025)

Figure 30. North America Flu Vaccine Sales Market Share by Application (2020-2025)

Figure 31. Asia-Pacific Flu Vaccine Revenue 2020-2031 (US$ Million)

Figure 32. Asia-Pacific Flu Vaccine Sales Market Share by Region (2020-2031)

Figure 33. Asia-Pacific Flu Vaccine Revenue Market Share by Region (2020-2031)

Figure 34. Asia-Pacific Flu Vaccine Sales Market Share by Type (2020-2025)

Figure 35. Asia-Pacific Flu Vaccine Sales Market Share by Application (2020-2025)

Figure 36. Europe Flu Vaccine Revenue Growth Rate 2020-2031 (US$ Million)

Figure 37. Europe Flu Vaccine Sales Market Share by Country (2020-2031)

Figure 38. Europe Flu Vaccine Revenue Market Share by Country (2020-2031)

Figure 39. Europe Flu Vaccine Sales Market Share by Type (2020-2025)

Figure 40. Europe Flu Vaccine Sales Market Share by Application (2020-2025)

Figure 41. Latin America Flu Vaccine Revenue Growth Rate 2020-2031 (US$ Million)

Figure 42. Latin America Flu Vaccine Sales Market Share by Country (2020-2031)

Figure 43. Latin America Flu Vaccine Revenue Market Share by Country (2020-2025)

Figure 44. Latin America Flu Vaccine Sales Market Share by Type (2020-2025)

Figure 45. Latin America Flu Vaccine Sales Market Share by Application (2020-2025)

Figure 46. Middle East and Africa Flu Vaccine Revenue Growth Rate 2020-2031 (US$ Million)

Figure 47. Middle East and Africa Flu Vaccine Sales Market Share by Country (2020-2031)

Figure 48. Middle East and Africa Flu Vaccine Revenue Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Flu Vaccine Sales Market Share by Type (2020-2025)

Figure 50. Middle East and Africa Flu Vaccine Sales Market Share by Application (2020-2025)

Figure 51. Flu Vaccine Supply Chain (Upstream and Downstream Market)

Figure 52. Global Production Market Share of Flu Vaccine Raw Materials by Region in 2024

Figure 53. Flu Vaccine Distribution Channels

Figure 54. Global Flu Vaccine Percentage 2020-2031: Indirect Sales VS Direct Sales

Figure 55. Global Flu Vaccine Percentage 2020-2031: Online Sales VS Offline Sales

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$5900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Flu Vaccine Market Insights Forecast to 2030

Global Injection Influenza Vaccine Market Research Report 2025

Global Human Injection Flu Vaccine Market Research Report 2025

Global Injection Flu Shot Market Research Report 2025

Children Influenza Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Flu RNA Vaccines Market Research Report 2025

Global Influenza Subunit Vaccine Market Research Report 2024

Global Adjuvanted Influenza Vaccine Market Research Report 2024

Global Influenza Therapeutics Market Insights Forecast to 2030

Global Flu Prevention Market Research Report 2024

Global Egg Based Flu Vaccines Market Research Report 2024

Global Egg free Flu Vaccine Market Research Report 2024

Global Recombinant Influenza Vaccine Market Research Report 2024

Global Paediatric Influenza Prevention Market Research Report 2024

Global Anti Influenza Virus Chinese Medicine Market Research Report 2024

Influenza Virus Vaccine H1N1 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Vaccine for Influenza Market Research Report 2025

Global Nasal Flu Vaccine Market Insights Forecast to 2030

Global Travelers Vaccines Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions